Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetics of Schizophrenia
Anil Srivastava, Oluwagbenga Dada, Jessica Qian, et al.
Psychiatry Research (2021) Vol. 305, pp. 114218-114218
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Neuronal dysfunction and gene modulation by non-coding RNA in Parkinson’s disease and synucleinopathies
Rosaria Meccariello, Gian Carlo Bellenchi, Salvatore Pulcrano, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 8
Identifying crucial biomarkers in peripheral blood of schizophrenia and screening therapeutic agents by comprehensive bioinformatics analysis
Mengtong Xie, Zhijun Li, Xinwei Li, et al.
Journal of Psychiatric Research (2022) Vol. 152, pp. 86-96
Closed Access | Times Cited: 31
Epigenetic Targets in Schizophrenia Development and Therapy
Agnieszka Wawrzczak‐Bargieła, Wiktor Bilecki, Marzena Maćkowiak
Brain Sciences (2023) Vol. 13, Iss. 3, pp. 426-426
Open Access | Times Cited: 17
Unlocking the Therapeutic Potential of Exosomes Derived From Nasal Olfactory Mucosal Mesenchymal Stem Cells: Restoring Synaptic Plasticity, Neurogenesis, and Neuroinflammation in Schizophrenia
Xiaolin Zhong, Yan Huang, Yang Du, et al.
Schizophrenia Bulletin (2023) Vol. 50, Iss. 3, pp. 600-614
Closed Access | Times Cited: 16
Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons—A Comprehensive Review
Antea Kršek, Leona Ostojić, Dorotea Zivalj, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9695-9695
Open Access | Times Cited: 6
Impact of Maternal Immune Activation on Nonhuman Primate Prefrontal Cortex Development: Insights for Schizophrenia
Kari L. Hanson, Simone Grant, Lucy H. Funk, et al.
Biological Psychiatry (2022) Vol. 92, Iss. 6, pp. 460-469
Open Access | Times Cited: 20
Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
Anwesha Gangopadhyay, Radwa Ibrahim, Karli Theberge, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 20
The 3-hit animal models of schizophrenia: Improving strategy to decipher and treat the disease?
Solenn Percelay, Caroline Lahogue, Jean‐Marie Billard, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 157, pp. 105526-105526
Closed Access | Times Cited: 4
Effects of Aripiprazole on Olanzapine Population Pharmacokinetics and Initial Dosage Optimization in Schizophrenia Patients
Cun Zhang, Lei Jiang, Ke Hu, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 479-490
Open Access | Times Cited: 4
What is the neurobiology of schizophrenia?
Michael A. Cummings, Ai-Li W. Arias, Stephen M. Stahl
CNS Spectrums (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 4
Investigating DRD2 and HTR2A polymorphisms in treatment-resistant schizophrenia: a comparative analysis with other treatment-resistant mental disorders and the healthy state
Antonio Del Casale, Giovanna Gentile, Simone Lardani, et al.
European Archives of Psychiatry and Clinical Neuroscience (2025)
Open Access
Quantitative analysis of literature on diagnostic biomarkers of Schizophrenia: revealing research hotspots and future prospects
Liuyin Jin, Linman Wu, Jing Zhang, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Schizophrenia in 22q11.2 Deletion Syndrome: A Case Report.
Sergio Cardona Bejarano, Lorena García‐Fernández
Psiquiatría Biológica (2025), pp. 100714-100714
Closed Access
Mendelian randomization reveals causalities between DNA methylation and schizophrenia
Danni Wang, Danyang Li, Xinglun Dang, et al.
Biological Psychiatry (2025)
Closed Access
Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention
Yafen Wang, Weicheng Meng, Zhixin Liu, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 18
MicroRNAs as potential biomarkers for diagnosis of schizophrenia and influence of antipsychotic treatment
Bridget Martinez, Philip V. Peplow
Neural Regeneration Research (2023) Vol. 19, Iss. 7, pp. 1523-1531
Open Access | Times Cited: 10
Epigenetic profile of the immune system associated with symptom severity and treatment response in schizophrenia
Yuanhao Tang, Yunlong Tan, Lena Palaniyappan, et al.
Journal of Psychiatry and Neuroscience (2024) Vol. 49, Iss. 1, pp. E45-E58
Open Access | Times Cited: 3
Peripheral Blood Non-Coding RNA as Biomarker for Schizophrenia: A Review
Mengtong Xie, Yanchi Zhang, Lijuan Yan, et al.
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 2
Open Access | Times Cited: 3
The molecular pathology of neurodegenerative and psychiatric disorders
Peipei Yan, Yi Deng, Xi Su, et al.
Elsevier eBooks (2023), pp. 3-43
Closed Access | Times Cited: 8
Gut microbes influence the development of central nervous system disorders through epigenetic inheritance
Tianyou Liu, Dongru Du, Rui Zhao, et al.
Microbiological Research (2023) Vol. 274, pp. 127440-127440
Open Access | Times Cited: 7
Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disorders
Brian J. Lopresti, Sarah K. Royse, Chester A. Mathis, et al.
Journal of Neurochemistry (2022) Vol. 164, Iss. 3, pp. 364-400
Closed Access | Times Cited: 12
Blood-Based MicroRNAs in Psychotic Disorders—A Systematic Review
Ștefania-Alexandra Grosu, Maria Dobre, Elena Milanesi, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2536-2536
Open Access | Times Cited: 6
Dysregulation of Serum Exosomal Lipid Metabolism in Schizophrenia: A Biomarker Perspective
Chenxi Xu, Wei Huang, Xiaojie Shi, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 2
YBX1‐Mediated DNA Methylation‐Dependent SHANK3 Expression in PBMCs and Developing Cortical Interneurons in Schizophrenia
Peiyan Ni, Chuqing Zhou, Sugai Liang, et al.
Advanced Science (2023) Vol. 10, Iss. 20
Open Access | Times Cited: 6
Abnormal expression of miR-3653-3p, caspase 1, IL-1β in peripheral blood of schizophrenia
Xinling Zhao, Yilin Liu, Qing Long, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top